{"id":"W4389803456","doi":"10.57264/cer-2023-0142","title":"Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer Pharmaceuticals; Pfizer","keywords":"Medicine; Blinatumomab; Refractory (planetary science); Lymphoblastic Leukemia; Retrospective cohort study; Internal medicine; Emergency medicine; Pediatrics; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005720687,0.0001589092,0.0002348804,0.0003803146,0.0001973379,0.0009472985,0.0002947435,0.0003265261,0.001564907],"category_scores_gemma":[0.003241671,0.0001571173,0.0004826937,0.0007125421,0.0001941678,0.0005448901,0.0004382427,0.0006141985,0.0001134199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009635927,"about_ca_system_score_gemma":0.0004330013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004946279,"about_ca_topic_score_gemma":0.007266681,"domain_scores_codex":[0.9992734,0.0002315002,0.0001003439,0.0001339724,0.0001283131,0.0001326353],"domain_scores_gemma":[0.9976572,0.0002615695,0.001790126,0.00005102064,0.00006156764,0.0001785244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004421732,0.00006062978,0.9962044,0.00002057392,0.0001769495,0.00005332312,0.00002604617,0.0002447396,0.0001026671,0.00005338397,0.0002112898,0.002403833],"study_design_scores_gemma":[0.00002799547,0.0001285921,0.9977837,0.00001660724,0.000071851,0.0002196587,0.0001662639,0.001039554,0.00007778664,0.00006088211,0.0004027162,0.00000437864],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986462,0.0005563434,0.0000336078,0.0001989334,0.000005924198,0.000003214925,0.0003533815,0.000001611892,0.0002007222],"genre_scores_gemma":[0.9993128,0.0001680276,0.0000372087,0.00005546873,0.0000097442,0.000003811243,0.0003652011,9.667813e-7,0.00004678683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004946279,"threshold_uncertainty_score":0.009835005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04128034902075604,"score_gpt":0.37272352712147,"score_spread":0.3314431781007139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}